A mycobacterial antigen ESAT-6 was identified in short-term culture filtrates of Mycobacterium tuberculosis and is easily found in patients with tuberculosis. This antigen contains a variety of epitopes recognized in more than 90% of patients. ESAT-6 has recently been shown to be an ideal candidate for diagnostic test that will discriminate between infected and BCG-vaccinated persons. ESAT-6 is mainly used for antibody production and development of test systems for tuberculosis. In the future the creation of a vaccine on the basis of ESAT-6 with liposomal adjuvant or polyoxidonium is possible. This protein is from Mycobacterium tuberculosis.

Target	6 kDa Early Secretory Antigenic Target (ESAT-6)
Origin	Bacteria
Expression	Recombinant
Host	E. coli
Conjugation	Unconjugated
Form	Liquid
Purity	> 99% (15% SDS-PAGE)96.72% (RP-HPLC)
Storage	Store between 10 and -20 °C.
Molecular Weight	11.2 kDa (ESI-TOF)
Sequence	AEQQWNFAGI EAAASAIQGN VTSIHSLLDE GKQSLTKLAA AWGGSGSEAY QGVQQKWDAT ATELNNALQN LARTISEAGQ AMASTEGNVT GMFAKLAAAL EHHHHHH
Tag	C-terminal His tag.
Buffer	50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 20% glycerol, 0.04% NaN3.
Concentration	0.8 mg/ml
Availability	Shipped within 5-10 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on 6 kDa Early Secretory Antigenic Target (ESAT-6) Protein 26S Proteasome Complex Subunit SEM1 (SEM1) shRNA abx972681  Specificity: SHFM1 shRNA Plasmid (Mouse) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized